Home › Atopic Dermatitis (Eczema) › Alabama › Birmingham
Pag-aaral pangklinika para sa Atopic Dermatitis (Eczema) sa Birmingham, AL
9 pag-aaral para sa Atopic Dermatitis (Eczema) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Birmingham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Nagre-recruitObservasyonal na pag-aaral
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Nagre-recruitPhase 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Nagre-recruitPhase 3
- Cahaba Dermatology & Skin Health Center, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Nagre-recruitPhase 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Nagre-recruitPhase 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Nagre-recruitPhase 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Nagre-recruitPhase 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Nagre-recruitPhase 2
- Allervie Clinical Research, Birmingham
Pag-aaral para sa Atopic Dermatitis (Eczema) sa ibang lungsod
- New York City, NY13 pag-aaral
- Los Angeles, CA11 pag-aaral
- Washington, DC11 pag-aaral
- San Antonio, TX10 pag-aaral
- San Diego, CA10 pag-aaral
- Miami, FL9 pag-aaral
- Dallas, TX8 pag-aaral
- Huntington Beach, CA8 pag-aaral
- Sacramento, CA8 pag-aaral
- Troy, MI8 pag-aaral
- Indianapolis, IN7 pag-aaral
- Tampa, FL7 pag-aaral
Iba pang pag-aaral sa Birmingham
- Kanser (lahat ng uri)31 pag-aaral
- Kanser sa Suso24 pag-aaral
- Kanser sa Ovary23 pag-aaral
- Obesity23 pag-aaral
- Non-Small Cell Lung Cancer22 pag-aaral
- Acute Myeloid Leukemia21 pag-aaral
- Multiple Myeloma18 pag-aaral
- COPD17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo17 pag-aaral
- Type 2 Diabetes16 pag-aaral
- Kanser ng Endometrium16 pag-aaral
- Overweight16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.